Albert Labs International Corp. operates as a research and drug development company. It produces natural pharmaceutical-quality psilocybin medicine to treat cancer-related distress. The firm focuses on improving patient access to psychedelic assisted therapies through accelerated regulatory approval pathways. The company is headquartered in Burnaby, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company